ARTICLE | Distillery Therapeutics
Therapeutics: GFT2I repeat domain containing 1 (GTF2IRD1); transforming growth factor β receptor II (TGFβ-RII; TGFBR2)
June 9, 2016 7:00 AM UTC
Patient sample and mouse studies suggest inhibiting TGFβ-RII could help treat GTF2IRD1-positive breast cancer. In breast cancer patients, high tumor levels of GTF2IRD1 correlated with disease progress...